MetLife, Inc.
MET
$76.56
$0.230.30%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 71.43B | 71.03B | 71.23B | 70.04B | 69.48B |
| Total Other Revenue | 499.00M | 1.97B | 2.27B | 936.00M | 1.86B |
| Total Revenue | 71.93B | 73.01B | 73.49B | 70.98B | 71.34B |
| Cost of Revenue | 54.48B | 54.23B | 54.53B | 53.46B | 53.10B |
| Gross Profit | 17.45B | 18.78B | 18.96B | 17.52B | 18.24B |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 12.48B | 12.25B | 12.12B | 11.98B | 11.93B |
| Total Operating Expenses | 66.96B | 66.48B | 66.65B | 65.44B | 65.03B |
| Operating Income | 4.97B | 6.53B | 6.84B | 5.54B | 6.31B |
| Income Before Tax | 4.93B | 5.71B | 5.93B | 5.62B | 5.18B |
| Income Tax Expenses | 1.06B | 1.41B | 1.41B | 1.18B | 1.40B |
| Earnings from Continuing Operations | 3.86K | 4.30K | 4.52K | 4.44K | 3.78K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -21.00M | -14.00M | -15.00M | -18.00M | -21.00M |
| Net Income | 3.84B | 4.29B | 4.50B | 4.43B | 3.76B |
| EBIT | 4.97B | 6.53B | 6.84B | 5.54B | 6.31B |
| EBITDA | 5.68B | 7.24B | 7.55B | 6.26B | 7.03B |
| EPS Basic | 5.35 | 5.94 | 6.18 | 6.00 | 4.99 |
| Normalized Basic EPS | 4.51 | 5.16 | 5.30 | 4.96 | 4.51 |
| EPS Diluted | 5.32 | 5.91 | 6.14 | 5.96 | 4.95 |
| Normalized Diluted EPS | 4.48 | 5.13 | 5.27 | 4.93 | 4.48 |
| Average Basic Shares Outstanding | 2.71B | 2.75B | 2.79B | 2.83B | 2.87B |
| Average Diluted Shares Outstanding | 2.73B | 2.76B | 2.80B | 2.84B | 2.89B |
| Dividend Per Share | 2.23 | 2.20 | 2.18 | 2.16 | 2.13 |
| Payout Ratio | 44.44% | 39.96% | 38.25% | 39.02% | 46.15% |